Co-expression of PKM2 and TRIM35 predicts survival and recurrence in hepatocellular carcinoma. (Q41597501)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25576919%20AND%20SRC:MED&resulttype=core&format=json

27 February 2020

title

Co-expression of PKM2 and TRIM35 predicts survival and recurrence in hepatocellular carcinoma (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25576919%20AND%20SRC:MED&resulttype=core&format=json

27 February 2020

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25576919%20AND%20SRC:MED&resulttype=core&format=json

27 February 2020

author name string

Zhiao Chen

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25576919%20AND%20SRC:MED&resulttype=core&format=json

27 February 2020

Xinyuan Lu

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25576919%20AND%20SRC:MED&resulttype=core&format=json

27 February 2020

Zhichao Wang

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25576919%20AND%20SRC:MED&resulttype=core&format=json

27 February 2020

Guangzhi Jin

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25576919%20AND%20SRC:MED&resulttype=core&format=json

27 February 2020

Qifeng Wang

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25576919%20AND%20SRC:MED&resulttype=core&format=json

27 February 2020

Di Chen

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25576919%20AND%20SRC:MED&resulttype=core&format=json

27 February 2020

Taoyang Chen

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25576919%20AND%20SRC:MED&resulttype=core&format=json

27 February 2020

Jinjun Li

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25576919%20AND%20SRC:MED&resulttype=core&format=json

27 February 2020

Jia Fan

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25576919%20AND%20SRC:MED&resulttype=core&format=json

27 February 2020

Wenming Cong

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25576919%20AND%20SRC:MED&resulttype=core&format=json

27 February 2020

Xianghuo He

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25576919%20AND%20SRC:MED&resulttype=core&format=json

27 February 2020

language of work or name

English

0 references

publication date

1 February 2015

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25576919%20AND%20SRC:MED&resulttype=core&format=json

27 February 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25576919%20AND%20SRC:MED&resulttype=core&format=json

27 February 2020

volume

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25576919%20AND%20SRC:MED&resulttype=core&format=json

27 February 2020

issue

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25576919%20AND%20SRC:MED&resulttype=core&format=json

27 February 2020

page(s)

2538-2548

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25576919%20AND%20SRC:MED&resulttype=core&format=json

L- and M2-pyruvate kinase expression in renal cell carcinomas and their metastases

27 February 2020

cites work

1 reference

12 December 2020

Tumor M2-pyruvate kinase in lung cancer patients: immunohistochemical detection and disease monitoring.

1 reference

12 December 2020

Evaluation of the Pyruvate Kinase isoenzyme tumor (Tu M2-PK) as a tumor marker for cervical carcinoma

1 reference

12 December 2020

Tumor type M2 pyruvate kinase (TuM2-PK) as a novel plasma tumor marker in melanoma

1 reference

12 December 2020

Tumour M2-pyruvate kinase: a gastrointestinal cancer marker

1 reference

12 December 2020

Hepatocellular carcinoma: epidemiology and molecular carcinogenesis

1 reference

12 December 2020

The M2 splice isoform of pyruvate kinase is important for cancer metabolism and tumour growth

1 reference

12 December 2020

High expression of macrophage colony-stimulating factor in peritumoral liver tissue is associated with poor survival after curative resection of hepatocellular carcinoma

1 reference

12 December 2020

Sensitivity and specificity of faecal tumour M2 pyruvate kinase for detection of colorectal adenomas in a large screening study

1 reference

12 December 2020

Cancer cell metabolism: Warburg and beyond

1 reference

12 December 2020

Gene expression in fixed tissues and outcome in hepatocellular carcinoma.

1 reference

12 December 2020

Clinical applications of metabolomics in oncology: a review

1 reference

12 December 2020

Overexpression of PD-L1 significantly associates with tumor aggressiveness and postoperative recurrence in human hepatocellular carcinoma

1 reference

12 December 2020

Cancer as a metabolic disease

1 reference

12 December 2020

Tumor-specific correlation of tumor M2 pyruvate kinase in pre-invasive, invasive and recurrent cervical cancer.

1 reference

12 December 2020

Global cancer statistics

1 reference

12 December 2020

Pyruvate kinase M2 is a PHD3-stimulated coactivator for hypoxia-inducible factor 1

1 reference

12 December 2020

Genome-wide copy number analyses identified novel cancer genes in hepatocellular carcinoma

1 reference

12 December 2020

Pyruvate kinase M2 regulates glucose metabolism by functioning as a coactivator for hypoxia-inducible factor 1 in cancer cells

1 reference

12 December 2020

No evidence for a shift in pyruvate kinase PKM1 to PKM2 expression during tumorigenesis

1 reference

12 December 2020

Hepatocellular carcinoma

1 reference

12 December 2020

Nuclear PKM2 regulates β-catenin transactivation upon EGFR activation

1 reference

12 December 2020

Comparative proteomic approach identifies PKM2 and cofilin-1 as potential diagnostic, prognostic and therapeutic targets for pulmonary adenocarcinoma

1 reference

12 December 2020

Pyruvate kinase M2 regulates gene transcription by acting as a protein kinase

1 reference

12 December 2020

CXCR6 upregulation contributes to a proinflammatory tumor microenvironment that drives metastasis and poor patient outcomes in hepatocellular carcinoma.

1 reference

12 December 2020

Emerging roles of PKM2 in cell metabolism and cancer progression

1 reference

12 December 2020

MicroRNAs: new tools for diagnosis, prognosis, and therapy in hepatocellular carcinoma?

1 reference

12 December 2020

Pyruvate kinase is a dosage-dependent regulator of cellular amino acid homeostasis

1 reference

12 December 2020

Cancer statistics, 2013

1 reference

12 December 2020

Regulation and function of pyruvate kinase M2 in cancer

1 reference

12 December 2020

Nuclear PKM2 regulates the Warburg effect.

1 reference

12 December 2020

Tissue-specific isoform switch and DNA hypomethylation of the pyruvate kinase PKM gene in human cancers.

1 reference

12 December 2020

PKM2 regulates chromosome segregation and mitosis progression of tumor cells.

1 reference

12 December 2020

Hepatic RIG-I predicts survival and interferon-α therapeutic response in hepatocellular carcinoma

1 reference

12 December 2020

miR-122 targets pyruvate kinase M2 and affects metabolism of hepatocellular carcinoma

1 reference

12 December 2020

Hepatocellular carcinoma: clinical frontiers and perspectives

1 reference

12 December 2020

New possibilities in hepatocellular carcinoma treatment

1 reference

12 December 2020

PKM2 as a biomarker for chemosensitivity to front-line platinum-based chemotherapy in patients with metastatic non-small-cell lung cancer.

1 reference

12 December 2020

TRIM35 Interacts with pyruvate kinase isoform M2 to suppress the Warburg effect and tumorigenicity in hepatocellular carcinoma

1 reference

12 December 2020